Inovio Pharmaceuticals Inc INO

NAS: INO | ISIN: US45773H2013 15/01/2026

1,580 USD (-3,66%)

(-3,66%) 15/01/2026

Grafiek Inovio Pharmaceuticals Inc

Grafiek Inovio Pharmaceuticals Inc

1 dag1d -3,66%
1 week1w 1,28%
1 maand1m -31,90%
3 maanden3m -35,77%
6 maanden6m 17,91%
1 jaar1j -17,28%
5 jaar5j -84,36%

Inovio Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

29 december 2025 · FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) · Persbericht

19 december 2025 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

18 november 2025 · INOVIO to Participate in December Investor Conferences · Persbericht

11 november 2025 · INOVIO Announces Pricing of $25 Million Public Offering · Persbericht

11 november 2025 · INOVIO Announces Proposed Public Offering · Persbericht

10 november 2025 · INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights · Persbericht

3 november 2025 · INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults · Persbericht

31 oktober 2025 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

27 oktober 2025 · INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 · Persbericht

23 oktober 2025 · INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference · Persbericht

Profiel Inovio Pharmaceuticals Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van wapens en munitie

Website: www.inovio.com

Hoofdzetel: San Diego, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe